Funds will support one of the largest interventional clinical trials of a full-spectrum microbiome product, and the largest ever to be conducted in IBSDosing of first patient of the Phase 2b ‘RISE’ ...

MA’s ZEPHYR Phase 2 trial in schizophrenia Last patient visit completed for ML-004’s IRIS Phase 2 trial in autism spectrum disorderTopline results from both Phase 2 trials expected by mid-August 2026 ...

Organ transplantation remains the cornerstone treatment for end-stage organ failure. While conventional broad-spectrum immunosuppression effectively controls acute rejection, it fails to address ...

Noema Pharma AG today announced the presentation of Phase 2a study results evaluating cendifensine in menopausal women ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ...

Foreign Secretary Vikram Misri joined UAE Minister of State for International Cooperation Reem Al Hashimy and France’s Secretary General for Europe and Foreign Affairs Martin Briens for the ...

Entropy Neurodynamics and LTR Pharma among ASX health companies reporting clinical milestones reached in quarterly results.

Customer Turnover Update -- The loss of a major single-serve cup customer in Q4 2025 is "fully behind us"; incoming volume ...

The Expected License Agreement Would Position Oragenics as the Only Company with Therapeutic Strategies Targeting TBI-Induced ...

Initial real-world results of patients receiving paltusotine suggest reduced symptoms and good tolerability, while a phase 3 ...

Columbus would not be the first city to try this kind of arrangement. An EPA case study describes a Microsoft-funded reuse ...